Involvement of the immune system in iodine deficient goiter

Area of Science:

• Endocrinology
• Immunology
• Pathology

Background:

• Iodine deficiency is a common cause of goiter, an enlargement of the thyroid gland.
• The role of immune cells and antigen presentation in the pathogenesis of goiter is not fully understood.

Purpose of the Study:

• To investigate the presence and characteristics of dendritic cells and other immune cells in iodine-deficient goiters.
• To examine the expression of MHC-class II and ICAM-1 on thyroid cells.
• To assess the iodination status of thyroglobulin and the effect of therapies on thyroid size and TGI levels.

Main Methods:

• Immunohistochemistry was used to study tissue samples from iodine-deficient goiters.
• Monoclonal antibodies were employed to detect specific cellular markers and thyroglobulin iodination.
• Thyroid size and circulating thyroid growth stimulating immunoglobulins (TGI) were measured before and after therapy.

Main Results:

• Extensive presence and typical arrangement of dendritic cells with high antigen-presenting capacity were observed.
• Dendritic cells were positive for MHC-class II epitopes and ICAM-1; epithelial follicle lining cells were class II positive but lacked ICAM-1.
• Thyroglobulin appeared not to be iodinated at the C-terminal hormogenic site. Both iodine and thyroxine therapies reduced thyroid size and TGI levels.

Conclusions:

• Dendritic cells play a significant role in the immune response within iodine-deficient goiters.
• Thyroid cells express MHC-class II, suggesting involvement in antigen presentation.
• Iodine and thyroxine therapies are effective in managing goiter by reducing thyroid size and suppressing TGI.